- Home
- CVM vs GNLN Comparison
CVM vs GNLN Comparison
Compare CVM & GNLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVM
- GNLN
- Stock Information
- Founded
- CVM 1983
- GNLN 2005
- Country
- CVM United States
- GNLN United States
- Employees
- CVM N/A
- GNLN N/A
- Industry
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- GNLN Durable Goods
- Sector
- CVM Health Care
- GNLN Consumer Discretionary
- Exchange
- CVM Nasdaq
- GNLN Nasdaq
- Market Cap
- CVM 11.8M
- GNLN 12.9M
- IPO Year
- CVM 1987
- GNLN 2019
- Fundamental
- Price
- CVM $3.46
- GNLN $3.19
- Analyst Decision
- CVM
- GNLN
- Analyst Count
- CVM 0
- GNLN 0
- Target Price
- CVM N/A
- GNLN N/A
- AVG Volume (30 Days)
- CVM 1.6M
- GNLN 2.3M
- Earning Date
- CVM 08-14-2025
- GNLN 08-13-2025
- Dividend Yield
- CVM N/A
- GNLN N/A
- EPS Growth
- CVM N/A
- GNLN N/A
- EPS
- CVM N/A
- GNLN N/A
- Revenue
- CVM N/A
- GNLN $9,818,000.00
- Revenue This Year
- CVM N/A
- GNLN $1,541.21
- Revenue Next Year
- CVM N/A
- GNLN N/A
- P/E Ratio
- CVM N/A
- GNLN N/A
- Revenue Growth
- CVM N/A
- GNLN N/A
- 52 Week Low
- CVM $1.98
- GNLN $2.86
- 52 Week High
- CVM $66.60
- GNLN $16,350.00
- Technical
- Relative Strength Index (RSI)
- CVM 57.66
- GNLN 29.39
- Support Level
- CVM $2.24
- GNLN $3.65
- Resistance Level
- CVM $2.71
- GNLN $7.47
- Average True Range (ATR)
- CVM 0.51
- GNLN 1.06
- MACD
- CVM 0.25
- GNLN 1.61
- Stochastic Oscillator
- CVM 25.61
- GNLN 4.31
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
About GNLN Greenlane Holdings Inc.
Greenlane Holdings Inc is a platform for the development and distribution of premium cannabis accessories, vape devices, and lifestyle products. It provides a wide array of consumer ancillary products and industrial ancillary products to thousands of cannabis producers, processors, brands, and retailers (Cannabis Operators). In addition, it serves specialty retailers, smoke shops, head shops, convenience stores, and consumers directly through its proprietary web stores and large online marketplaces such as Amazon. Its geographical segment includes the United States, Canada, and Europe. It derives a majority of revenue from the United States.